Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Volatile Organic Compounds for the Assessment of Liver Disease: Assessment of Hepatobiliary Disease Through Non-Invasive Detection of Exhaled Volatile Organic Compounds

NCT04620538 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04620538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Volatile Organic Compounds for the Assessment of Liver Disease: Assessment of Hepatobiliary Disease Through Non-Invasive Detection of Exhaled Volatile Organic Compounds
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
March 26, 2026
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, cirrhosis, liver, fibrosis, liver, hepatocellular cancer, hepatocellular carcinoma